Global Stem Cell Assay Market Overview
Stem Cell Assay Market was valued at US$ 2.5 Billion in 2024 and is projected to grow at a CAGR of 17.90% to reach US$ 11.2 Billion by 2034.
Stem cells refer to the undifferentiated biological cells that differentiate into specialized cells and divide to produce more stem cells. They are found in multicellular organisms and are of two type’s mainly embryonic stem cells and adult stem cells. Stem cell assays involve the technique of analyzing living cell on the basis of different parameters such as shape, size, and others. These assays are used to measure biochemical and cellular functions using functional cells as diagnostic tools in the research of new drugs. Stem cell assays are also used to measure cell proliferations, motility, and toxicity.
Global Stem Cell Assay Market Dynamics
The major factors boosting the growth of the stem cell assay market include rising expenditure in research-related activities, advancement in technologies, and increased frequency of chronic diseases. However, the growth of the market can be hindered owing to the huge cost of stem cell-based therapies and strict regulatory recommendation. Rise in approvals of clinical trials for stem cell based therapy, high prevalence of chronic diseases, increase in research related activities in stem cells, and technological advancements in the area of stem cell assays method supplements the growth of the stem cell assay market. However, dearth of skilled professionals for analyzing stem cells, high cost of instruments and stem cell based therapies, and stringent intellectual property rights impede the growth of stem cells assay market. The increase in evolution of new technologies and rise in the patient pool provides opportunities for the growth of the global market during the forecast period. Stem cells have the potential to treat a wide range of diseases. The major investments in the field and scope of medical biotechnology are supposed to boost the growth of stem cell assay market during the forecast period.
Global Stem Cell Assay Market Segmentation
Stem cell assay market is segmented based on type, kit, detection, instruments, application, end user, and region.
Based on type, the stem cell assay market is segmented into viability/cytotoxicity, isolation/purification, cell identification, proliferation, cell differentiation, cell function, and cell apoptosis assays. Based on the kit, the target market is segmented into adult stem cells kit and human embryonic stem cells kit, led by the rise in product innovation activities and increasing focus on drug screening by biotechnology and pharmaceutical industries. The adult stem cell kit are projected to witness the highest CAGR during the forecast period due to the ease of use, cost & effectiveness of this type of kit in stem cell analysis. Based on detection, the global market is classified into instruments and detection kits. Based on instrument the stem cell assay market is separated into flow cytometer, micro electrode arrays, cell imaging systems, and automated cell counter. Based on application, the target market is bifurcated into regenerative medicine and therapy development, drug discovery & development and clinical research. Based on end user, the targeted market is segmented into government research institutes, private research, and industry research. The industry research segment is projected to account for the major share of the stem cell assay market during the forecast period.
Based on the region the stem cell assay market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the stem cell assay market due to growing demand for advanced medical technologies and increasing geriatric population. Asia Pacific stem cell assay market is projected to register a high CAGR over the forecast period owing to the growing trend of regenerative medicines & therapy development market is to dominate the stem cell assay market. Regenerative medicine helps the natural remedial processes which work more effectively and more quickly.
Stem Cell Assay Market, By Type:
- Viability/Cytotoxicity
- Isolation/Purification
- Cell Identification
- Proliferation
- Cell Differentiation
- Cell Function
- Cell Apoptosis Assays
Stem Cell Assay Market, By Kit:
- Adult Stem Cells Kit
- Human Embryonic Stem Cells Kits
Stem Cell Assay Market, By Detection:
- Instruments
- Detection Kits
Stem Cell Assay Market, By Instruments:
- Flow Cytometer
- Micro Electrode Arrays
- Cell Imaging Systems
- Automated Cell Counter
Stem Cell Assay Market, By Application:
- Regenerative Medicine And Therapy Development
- Drug Discovery & Development
- Clinical Research
Stem Cell Assay Market, By End User:
- Government Research Institutes
- Private Research
- Industry Research
Stem Cell Assay Market, By Region:
- North America
- North America Stem Cell Assay Market, By Type
- North America Stem Cell Assay Market, By Kit
- North America Stem Cell Assay Market, By Detection
- North America Stem Cell Assay Market, By Instrument
- North America Stem Cell Assay Market, By Application
- North America Stem Cell Assay Market, By End User
- North America Stem Cell Assay Market, By Country
- The U.S.
- Canada
- Europe
- Europe Stem Cell Assay Market, By Type
- Europe Stem Cell Assay Market, By Kit
- Europe Stem Cell Assay Market, By Detection
- Europe Stem Cell Assay Market, By Instrument
- Europe Stem Cell Assay Market, By Application
- Europe Stem Cell Assay Market, By End User
- Europe Stem Cell Assay Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Stem Cell Assay Market, By Type
- Asia Pacific Stem Cell Assay Market, By Kit
- Asia Pacific Stem Cell Assay Market, By Detection
- Asia Pacific Stem Cell Assay Market, By Instrument
- Asia Pacific Stem Cell Assay Market, By Application
- Asia Pacific Stem Cell Assay Market, By End User
- Asia Pacific Stem Cell Assay Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Stem Cell Assay Market, By Type
- Latin America Stem Cell Assay Market, By Kit
- Latin America Stem Cell Assay Market, By Detection
- Latin America Stem Cell Assay Market, By Instrument
- Latin America Stem Cell Assay Market, By Application
- Latin America Stem Cell Assay Market, By End User
- Latin America Stem Cell Assay Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Stem Cell Assay Market, By Type
- Middle East & Africa Stem Cell Assay Market, By Kit
- Middle East & Africa Stem Cell Assay Market, By Detection
- Middle East & Africa Stem Cell Assay Market, By Instrument
- Middle East & Africa Stem Cell Assay Market, By Application
- Middle East & Africa Stem Cell Assay Market, By End User
- Middle East & Africa Stem Cell Assay Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Stem Cell Assay Market Key Players
The key players operating the stem cell assay market involves GE Healthcare, Promega Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Cell Biolabs, Inc., Hemogenix, STEMCELL Technologies Inc., Bio-Rad Laboratories Inc., R&D Systems Inc., and Cellular Dynamics International Inc. These companies have a broad product portfolio with comprehensive features and have also expanded their presence geographically. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.
Global Stem Cell Assay Market Company Profile
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Promega Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cell Biolabs, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- STEMCELL Technologies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- R&D Systems Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cellular Dynamics International Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hemogenix
- Company Overview
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Promega Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cell Biolabs, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- STEMCELL Technologies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- R&D Systems Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cellular Dynamics International Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hemogenix
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
FAQs
The Global Stem Cell Assay Market is valued at US$659.42 million in 2019
The Stem Cell Assay Market is projected to increase at a CAGR of 17.90% during the forecast period.
The global stem cell assay market is segmented based on type, kit, detection, instruments, application, end user, and region.
The major factors boosting the growth of the global stem cell assay market include rising expenditure in research-related activities, advancement in technologies, and increased frequency of chronic diseases.
The global stem cell assay market is dominated by North America, followed by Europe. North America will continue to dominate the global stem cell assay market in the forecast period.
Companies are broadening product portfolio with comprehensive features and are also into expanding their presence geographically.